SlideShare ist ein Scribd-Unternehmen logo
1 von 33
Downloaden Sie, um offline zu lesen
Exploring Antimalarial Drugs
Read the daily message and record notes of
important points and deliverables. (5 min)
Open your pinned Daily Message Notes
• Interns should add today’s date and the subject of
the message (Drugs to Treat Malaria) at the top
of the note. All of the notes they take for this
message should fall under this heading.
• Add (Copy/Paste) summary of deliverables and/or
important information under heading.
NSEI 4.1 WARM-UP
Interns interpret two types of visual representations of a malaria parasite population to
understand the distribution of drug resistance traits.
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
Key Points:
• Using a single-drug treatment results in the distribution of traits in a
malaria population that shift toward having more resistance to the drug
used in that treatment.
• Once there is high resistance to a drug, that drug may no longer effectively
treat malaria and the population will increase.
• Preventing an increase in the total population of malaria parasites is a
constraint of this engineering problem.
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
Each parasite is
represented once on each
histogram.
Each pair of histograms (top
and bottom) show the same
population visualized in two
different ways
1. sorted according to the
parasites’ resistance to
Red Drug (top histogram
in the set),
2. and then sorted
according to the
parasites’ resistance to
the Blue Drug (bottom
histogram in the set).
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
•The histograms on the left
show the initial population,
before any drug was
applied. The histograms on
the right show the same
population after treatment
with Red Drug. It is clear
that the distribution of traits
have shifted.
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
•The top histograms show
changes in the number of
individuals with traits for
resistance to Red Drug (red
stripes) at a some specific
points in time. The bottom
set of histograms reflects
the same population, but
focusing on the number of
individuals with traits for
resistance to Blue Drug
(blue stripes).
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
•Trace the connection
between the initial
population diagram and
each histogram set, pointing
out how the one individual
with high resistance to Red
Drug is shown in the top
histogram, and the
remaining five individuals
account for none (no traits
for resistance to Red Drug).
The fact that some parasites
have blue stripes
(resistance to Blue Drug) is
of no interest when
constructing the Red Drug
histogram.
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
•Repeat this same thought
exercise using the Blue
Drug and the histograms at
the bottom of the projection:
there is one individual with
the trait for high resistance
to Blue Drug (two blue
stripes), one with some
resistance (one blue stripe),
and the remaining four have
no traits for resistance to
Blue Drug.
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
•Why has the percentage of the
population with high resistance
to Red Drug increased?
•Because the treatment that
used the Red Drug didn’t kill
those individuals with high
resistance to Red Drug, so
more survived and can continue
to reproduce.
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
•Why has the percentage of the
population with high resistance
to Blue Drug decreased?
•Because the treatment that
used Red Drug killed most of
those individuals with no
resistance to Red Drug. Even if
the individuals had a high
resistance to a different drug
(Blue), that did not help them in
the presence of Red Drug, and
they were killed.
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
•What do you expect to see if
you treat the same initial
population with the Blue Drug?
•The percentage of the
population with traits for
resistance to Blue Drug will
increase, but the percentage of
population with traits for
resistance to Red Drug will
decrease.
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
•Note that many individuals with
resistance to Blue Drug
survived the use of that drug
and then reproduced, passing
their traits for resistance to the
offspring.
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
• Recall the MalariaMed histograms showing the traits
for resistance to three different drugs: A, B, and C.
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
• Recall the MalariaMed histograms showing the traits
for resistance to three different drugs: A, B, and C.
NSEI ANALYZING DIAGRAMS AND HISTOGRAMS
• Recall the MalariaMed histograms showing the traits
for resistance to three different drugs: A, B, and C.
NSEI 1.4.2 READING
ANTIMALARIAL DRUG RESISTANCE
Interns use Active Reading to learn about and then summarize the characteristics of the
antimalarial drugs they can use in their malaria treatments.
Open the Futura Biomedical Engineer’s Dossier.
Selecting the link in the Daily Message and use the table of
contents to navigate to Chapter 5: “Antimalarial Drugs.”
• Today’s research describes the characteristics of each
drug and how they affect the project criteria. Review
the three project criteria, if desired.
• Locate the Pros and Cons of Antimalarial Drugs table
from Analyzing Single-Drug Treatments sheet from the
previous day. Add items to the table as you read.
• Actively read and annotate this section of the Dossier.
NSEI 4.2 READING
ANTIMALARIAL DRUG RESISTANCE
Key Points
• Different drugs are more or less effective at killing parasites than
others. More effective drugs will shift the distribution of traits
toward drug resistance more quickly.
• Different drugs cause different patient side effects, some of which
can interfere with an effective drug treatment if the side effects are
more serious. Review the meaning of the words mild, moderate,
and severe, as necessary.
• It is important to consider cost when designing malaria treatments
so that it is accessible to those who need it most.
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
Interns continue to run isolated tests in MalariaMed to understand how different drugs, doses, and numbers of
treatment days affect the project criteria.
• List the things you can
change in MalariaMed.
• drug type,
• drug dose,
• number of days.
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
• What variable was
isolated in the single-
drug treatment analysis.
• Drug type: for each
test we used only
one drug: A, B, or C
• In those single-drug tests you were testing for the effects of each drug
type; you isolated the drug type variable, and kept the number of days
and dose size the same in each test.
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
• When you did the single-
drug treatments tests, you
gathered data about how
each drug type affected a
malaria treatment, keeping
dose size and number of
days the same.
• Today, you will use
MalariaMed to investigate
these questions by
isolating different
variables: either number of
days or dose size.
How do you think you could use
MalariaMed to figure out how dose size
might affect a single-drug treatment?
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
For today’s testing you and your
partner are going to vary the size of
the dose, and the number of testable
days.
For example:
One partner could test Drug A for
three days at large doses while
the other partner tests Drug A for
three days at small doses. Interns
could then do another test for a
different number of days or for a
different drug.
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
Review the histograms with each test
and record observations, just as you
did yesterday during the Analyzing
Single-Drug Treatments task.
Complete at least three tests, and
discuss your results and record your
ideas on the Conclusions table.
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
Summarize your conclusions
for Total Parasite Population.
If you don’t use enough
days of the drug, too many
parasites can survive and
the population will increase.
If you use larger doses,
more parasites will die
(depends on drug) and the
population will increase.
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
Summarize your conclusions
for Drug Resistance.
When using large doses, the
percentage of resistance is higher
after 10 years, and you see
parasites with high resistance in
fewer years compared to small
doses. When using one drug for
only 1–3 days, the percentage of
resistance is smaller after 10
years, and it takes more years to
see parasites with high resistance
compared to treatments that are
5–7 days.
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
Are the trends the same for all
drugs? Discuss why or why
not..
Drug B already has individuals
with high resistance so using only
that drug results in the majority
(larger percent) of population with
traits for high resistance in fewer
years. Drug C is the least
effective drug, so it takes longer
to see parasites with high
resistance, or the final percentage
is lower compared to other drugs.
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
Summarize your conclusions
for Patient Side Effects.
In general, fewer days
of a drug result in lower
side effects, but it
depends on the drug.
Small doses of a drug
result in lower side
effects.
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
Summarize your conclusions
for Total Cost.
Fewer days of a drug
result in lower costs
(depends on drug).
Smaller doses cost less
so treatment costs are
lower.
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
Use evidence from the Dossier to help
explain why you are seeing these
results.
If you don’t use large enough doses, even
those individuals with some resistance can
survive and reproduce to pass on their
traits; Those individuals with no resistance
are more likely to survive a low dose, and
all surviving individuals have a chance of
producing offspring that develop mutations
for stronger drug resistance; If you don’t
use drugs for enough days, you will see
something similar—more individuals
surviving, reproducing, and possibly
producing offspring which have developed
traits for higher drug resistance through
mutation.
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
What might happen to the population if
more than one drug is used?
Resistance would be
minimized because it is likely
that the second drug would kill
the parasites that were
resistant to the first drug.
NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
What might happen to the population if
more than one drug is used?
Resistance would be
minimized because it is likely
that the second drug would kill
the parasites that were
resistant to the first drug.
NSEI 4.3 AFTER-HOURS WORK
Complete the Project Summary form as a prewriting activity for the introduction of the
final proposal.
You have worked with the
different antimalarial drugs
today and have learned
more about how each
contributes to the various
project criteria. This form will
be submitted to our project
leader Ken so he can see
what interns understand
about the project and some
early ideas about malaria
treatment designs.
NSEI 4.3 AFTER-HOURS WORK

Weitere ähnliche Inhalte

Ähnlich wie Exploring Antimalarial Drugs

A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
 A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI... A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...M.Arumuga Vignesh
 
ACDRS Talk Tamura Oct 2009 1
ACDRS Talk Tamura  Oct 2009 1ACDRS Talk Tamura  Oct 2009 1
ACDRS Talk Tamura Oct 2009 1rm60553
 
Causality assessment scale
Causality assessment scaleCausality assessment scale
Causality assessment scaledrarunsingh4
 
Using Tableau to Reveal Healthcare Insights
Using Tableau to Reveal Healthcare InsightsUsing Tableau to Reveal Healthcare Insights
Using Tableau to Reveal Healthcare InsightsStarschema
 
Using tableau to reveal healthcare insights
Using tableau to reveal healthcare insightsUsing tableau to reveal healthcare insights
Using tableau to reveal healthcare insightsStarschema
 
General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
 General prescribing guidelines for Pediatrics geriatrics pregnancy lactating... General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...Koppala RVS Chaitanya
 
Measurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiologyMeasurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiologyDr. Ashish singh parihar
 
Changing treatment and drug resistance
Changing treatment and drug resistanceChanging treatment and drug resistance
Changing treatment and drug resistanceITPCMENA
 
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptxPolypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptxAhmed Mshari
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyAsma Ashraf
 
For this Discussion, review the case Learning Resources and the
For this Discussion, review the case Learning Resources and the For this Discussion, review the case Learning Resources and the
For this Discussion, review the case Learning Resources and the DustiBuckner14
 
LDI Research Seminar 2_18_11 The Diversity of Concentrated Prescribing Behavi...
LDI Research Seminar 2_18_11 The Diversity of Concentrated Prescribing Behavi...LDI Research Seminar 2_18_11 The Diversity of Concentrated Prescribing Behavi...
LDI Research Seminar 2_18_11 The Diversity of Concentrated Prescribing Behavi...Leonard Davis Institute of Health Economics
 
Bioequivalance and drug product assesment seminar 2020
Bioequivalance and drug product assesment seminar 2020Bioequivalance and drug product assesment seminar 2020
Bioequivalance and drug product assesment seminar 2020SoumyadipGhosh19
 
Evaluation of the evidence of the drug development
Evaluation of the evidence of the drug developmentEvaluation of the evidence of the drug development
Evaluation of the evidence of the drug developmentaJaY mIsHrA
 

Ähnlich wie Exploring Antimalarial Drugs (20)

A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
 A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI... A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
A PROSPECTIVE STUDY OF DRUG UTILIZATION PATTERN AND EVALUATION USING WHO GUI...
 
ACDRS Talk Tamura Oct 2009 1
ACDRS Talk Tamura  Oct 2009 1ACDRS Talk Tamura  Oct 2009 1
ACDRS Talk Tamura Oct 2009 1
 
Causality assessment scale
Causality assessment scaleCausality assessment scale
Causality assessment scale
 
Using Tableau to Reveal Healthcare Insights
Using Tableau to Reveal Healthcare InsightsUsing Tableau to Reveal Healthcare Insights
Using Tableau to Reveal Healthcare Insights
 
Using tableau to reveal healthcare insights
Using tableau to reveal healthcare insightsUsing tableau to reveal healthcare insights
Using tableau to reveal healthcare insights
 
General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
 General prescribing guidelines for Pediatrics geriatrics pregnancy lactating... General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
General prescribing guidelines for Pediatrics geriatrics pregnancy lactating...
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Measurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiologyMeasurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiology
 
Changing treatment and drug resistance
Changing treatment and drug resistanceChanging treatment and drug resistance
Changing treatment and drug resistance
 
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptxPolypharmacy and Rational Prescribing in Elderly Patients.pptx
Polypharmacy and Rational Prescribing in Elderly Patients.pptx
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
OBE Impact Measurement.ppt
OBE Impact Measurement.pptOBE Impact Measurement.ppt
OBE Impact Measurement.ppt
 
For this Discussion, review the case Learning Resources and the
For this Discussion, review the case Learning Resources and the For this Discussion, review the case Learning Resources and the
For this Discussion, review the case Learning Resources and the
 
P-DRUG.pptx
P-DRUG.pptxP-DRUG.pptx
P-DRUG.pptx
 
Mdr tuberculosis
Mdr tuberculosisMdr tuberculosis
Mdr tuberculosis
 
LDI Research Seminar 2_18_11 The Diversity of Concentrated Prescribing Behavi...
LDI Research Seminar 2_18_11 The Diversity of Concentrated Prescribing Behavi...LDI Research Seminar 2_18_11 The Diversity of Concentrated Prescribing Behavi...
LDI Research Seminar 2_18_11 The Diversity of Concentrated Prescribing Behavi...
 
Bioequivalance and drug product assesment seminar 2020
Bioequivalance and drug product assesment seminar 2020Bioequivalance and drug product assesment seminar 2020
Bioequivalance and drug product assesment seminar 2020
 
Pharmacoepideiology
PharmacoepideiologyPharmacoepideiology
Pharmacoepideiology
 
Mpharm RA 103.pdf
Mpharm RA 103.pdfMpharm RA 103.pdf
Mpharm RA 103.pdf
 
Evaluation of the evidence of the drug development
Evaluation of the evidence of the drug developmentEvaluation of the evidence of the drug development
Evaluation of the evidence of the drug development
 

Mehr von dwinter1

Composing The Final Proposal
Composing The Final ProposalComposing The Final Proposal
Composing The Final Proposaldwinter1
 
Writing Design Decisions
Writing Design DecisionsWriting Design Decisions
Writing Design Decisionsdwinter1
 
Considering Design Decisions
Considering Design DecisionsConsidering Design Decisions
Considering Design Decisionsdwinter1
 
Writing A Scientific Argument
Writing A Scientific ArgumentWriting A Scientific Argument
Writing A Scientific Argumentdwinter1
 
Engaging In A Science Seminar
Engaging In A Science SeminarEngaging In A Science Seminar
Engaging In A Science Seminardwinter1
 
Examining Evidence About Sticklebacks
Examining Evidence About SticklebacksExamining Evidence About Sticklebacks
Examining Evidence About Sticklebacksdwinter1
 
Wrapping Up The Newt Mystery
Wrapping Up The Newt MysteryWrapping Up The Newt Mystery
Wrapping Up The Newt Mysterydwinter1
 
Mutations In a Population
Mutations In a PopulationMutations In a Population
Mutations In a Populationdwinter1
 
Introduction to Mutations
Introduction to MutationsIntroduction to Mutations
Introduction to Mutationsdwinter1
 
Reviewing Key Ideas About Natural Selection
Reviewing Key Ideas About Natural SelectionReviewing Key Ideas About Natural Selection
Reviewing Key Ideas About Natural Selectiondwinter1
 
The Deadly Dare
The Deadly DareThe Deadly Dare
The Deadly Daredwinter1
 
Reasoning About The Newt Mystery
Reasoning About The Newt MysteryReasoning About The Newt Mystery
Reasoning About The Newt Mysterydwinter1
 
Survival and Reproduction
Survival and ReproductionSurvival and Reproduction
Survival and Reproductiondwinter1
 
Reproduction and Traits
Reproduction and TraitsReproduction and Traits
Reproduction and Traitsdwinter1
 
Explaining Changes in Trait Distribution
Explaining Changes in Trait DistributionExplaining Changes in Trait Distribution
Explaining Changes in Trait Distributiondwinter1
 
Adaptive Traits
Adaptive TraitsAdaptive Traits
Adaptive Traitsdwinter1
 
Investigating Changes In Trait Distribution
Investigating Changes In Trait DistributionInvestigating Changes In Trait Distribution
Investigating Changes In Trait Distributiondwinter1
 
Exploring Variation and Distribution in Populations
Exploring Variation and Distribution in PopulationsExploring Variation and Distribution in Populations
Exploring Variation and Distribution in Populationsdwinter1
 
Natural Selection - The Mystery of the Poisonous Newt
Natural Selection - The Mystery of the Poisonous NewtNatural Selection - The Mystery of the Poisonous Newt
Natural Selection - The Mystery of the Poisonous Newtdwinter1
 
Writing an Argument About the Channel on Mars
Writing an Argument About the Channel on MarsWriting an Argument About the Channel on Mars
Writing an Argument About the Channel on Marsdwinter1
 

Mehr von dwinter1 (20)

Composing The Final Proposal
Composing The Final ProposalComposing The Final Proposal
Composing The Final Proposal
 
Writing Design Decisions
Writing Design DecisionsWriting Design Decisions
Writing Design Decisions
 
Considering Design Decisions
Considering Design DecisionsConsidering Design Decisions
Considering Design Decisions
 
Writing A Scientific Argument
Writing A Scientific ArgumentWriting A Scientific Argument
Writing A Scientific Argument
 
Engaging In A Science Seminar
Engaging In A Science SeminarEngaging In A Science Seminar
Engaging In A Science Seminar
 
Examining Evidence About Sticklebacks
Examining Evidence About SticklebacksExamining Evidence About Sticklebacks
Examining Evidence About Sticklebacks
 
Wrapping Up The Newt Mystery
Wrapping Up The Newt MysteryWrapping Up The Newt Mystery
Wrapping Up The Newt Mystery
 
Mutations In a Population
Mutations In a PopulationMutations In a Population
Mutations In a Population
 
Introduction to Mutations
Introduction to MutationsIntroduction to Mutations
Introduction to Mutations
 
Reviewing Key Ideas About Natural Selection
Reviewing Key Ideas About Natural SelectionReviewing Key Ideas About Natural Selection
Reviewing Key Ideas About Natural Selection
 
The Deadly Dare
The Deadly DareThe Deadly Dare
The Deadly Dare
 
Reasoning About The Newt Mystery
Reasoning About The Newt MysteryReasoning About The Newt Mystery
Reasoning About The Newt Mystery
 
Survival and Reproduction
Survival and ReproductionSurvival and Reproduction
Survival and Reproduction
 
Reproduction and Traits
Reproduction and TraitsReproduction and Traits
Reproduction and Traits
 
Explaining Changes in Trait Distribution
Explaining Changes in Trait DistributionExplaining Changes in Trait Distribution
Explaining Changes in Trait Distribution
 
Adaptive Traits
Adaptive TraitsAdaptive Traits
Adaptive Traits
 
Investigating Changes In Trait Distribution
Investigating Changes In Trait DistributionInvestigating Changes In Trait Distribution
Investigating Changes In Trait Distribution
 
Exploring Variation and Distribution in Populations
Exploring Variation and Distribution in PopulationsExploring Variation and Distribution in Populations
Exploring Variation and Distribution in Populations
 
Natural Selection - The Mystery of the Poisonous Newt
Natural Selection - The Mystery of the Poisonous NewtNatural Selection - The Mystery of the Poisonous Newt
Natural Selection - The Mystery of the Poisonous Newt
 
Writing an Argument About the Channel on Mars
Writing an Argument About the Channel on MarsWriting an Argument About the Channel on Mars
Writing an Argument About the Channel on Mars
 

Kürzlich hochgeladen

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdfssuserdda66b
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxJisc
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfSherif Taha
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxEsquimalt MFRC
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the ClassroomPooky Knightsmith
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...pradhanghanshyam7136
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701bronxfugly43
 

Kürzlich hochgeladen (20)

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 

Exploring Antimalarial Drugs

  • 2. Read the daily message and record notes of important points and deliverables. (5 min) Open your pinned Daily Message Notes • Interns should add today’s date and the subject of the message (Drugs to Treat Malaria) at the top of the note. All of the notes they take for this message should fall under this heading. • Add (Copy/Paste) summary of deliverables and/or important information under heading. NSEI 4.1 WARM-UP
  • 3. Interns interpret two types of visual representations of a malaria parasite population to understand the distribution of drug resistance traits. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS Key Points: • Using a single-drug treatment results in the distribution of traits in a malaria population that shift toward having more resistance to the drug used in that treatment. • Once there is high resistance to a drug, that drug may no longer effectively treat malaria and the population will increase. • Preventing an increase in the total population of malaria parasites is a constraint of this engineering problem.
  • 4. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS Each parasite is represented once on each histogram. Each pair of histograms (top and bottom) show the same population visualized in two different ways 1. sorted according to the parasites’ resistance to Red Drug (top histogram in the set), 2. and then sorted according to the parasites’ resistance to the Blue Drug (bottom histogram in the set).
  • 5. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS •The histograms on the left show the initial population, before any drug was applied. The histograms on the right show the same population after treatment with Red Drug. It is clear that the distribution of traits have shifted.
  • 6. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS •The top histograms show changes in the number of individuals with traits for resistance to Red Drug (red stripes) at a some specific points in time. The bottom set of histograms reflects the same population, but focusing on the number of individuals with traits for resistance to Blue Drug (blue stripes).
  • 7. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS •Trace the connection between the initial population diagram and each histogram set, pointing out how the one individual with high resistance to Red Drug is shown in the top histogram, and the remaining five individuals account for none (no traits for resistance to Red Drug). The fact that some parasites have blue stripes (resistance to Blue Drug) is of no interest when constructing the Red Drug histogram.
  • 8. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS •Repeat this same thought exercise using the Blue Drug and the histograms at the bottom of the projection: there is one individual with the trait for high resistance to Blue Drug (two blue stripes), one with some resistance (one blue stripe), and the remaining four have no traits for resistance to Blue Drug.
  • 9. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS •Why has the percentage of the population with high resistance to Red Drug increased? •Because the treatment that used the Red Drug didn’t kill those individuals with high resistance to Red Drug, so more survived and can continue to reproduce.
  • 10. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS •Why has the percentage of the population with high resistance to Blue Drug decreased? •Because the treatment that used Red Drug killed most of those individuals with no resistance to Red Drug. Even if the individuals had a high resistance to a different drug (Blue), that did not help them in the presence of Red Drug, and they were killed.
  • 11. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS •What do you expect to see if you treat the same initial population with the Blue Drug? •The percentage of the population with traits for resistance to Blue Drug will increase, but the percentage of population with traits for resistance to Red Drug will decrease.
  • 12. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS •Note that many individuals with resistance to Blue Drug survived the use of that drug and then reproduced, passing their traits for resistance to the offspring.
  • 13. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS • Recall the MalariaMed histograms showing the traits for resistance to three different drugs: A, B, and C.
  • 14. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS • Recall the MalariaMed histograms showing the traits for resistance to three different drugs: A, B, and C.
  • 15. NSEI ANALYZING DIAGRAMS AND HISTOGRAMS • Recall the MalariaMed histograms showing the traits for resistance to three different drugs: A, B, and C.
  • 16. NSEI 1.4.2 READING ANTIMALARIAL DRUG RESISTANCE Interns use Active Reading to learn about and then summarize the characteristics of the antimalarial drugs they can use in their malaria treatments. Open the Futura Biomedical Engineer’s Dossier. Selecting the link in the Daily Message and use the table of contents to navigate to Chapter 5: “Antimalarial Drugs.” • Today’s research describes the characteristics of each drug and how they affect the project criteria. Review the three project criteria, if desired. • Locate the Pros and Cons of Antimalarial Drugs table from Analyzing Single-Drug Treatments sheet from the previous day. Add items to the table as you read. • Actively read and annotate this section of the Dossier.
  • 17. NSEI 4.2 READING ANTIMALARIAL DRUG RESISTANCE Key Points • Different drugs are more or less effective at killing parasites than others. More effective drugs will shift the distribution of traits toward drug resistance more quickly. • Different drugs cause different patient side effects, some of which can interfere with an effective drug treatment if the side effects are more serious. Review the meaning of the words mild, moderate, and severe, as necessary. • It is important to consider cost when designing malaria treatments so that it is accessible to those who need it most.
  • 18. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES Interns continue to run isolated tests in MalariaMed to understand how different drugs, doses, and numbers of treatment days affect the project criteria. • List the things you can change in MalariaMed. • drug type, • drug dose, • number of days.
  • 19. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES • What variable was isolated in the single- drug treatment analysis. • Drug type: for each test we used only one drug: A, B, or C • In those single-drug tests you were testing for the effects of each drug type; you isolated the drug type variable, and kept the number of days and dose size the same in each test.
  • 20. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES • When you did the single- drug treatments tests, you gathered data about how each drug type affected a malaria treatment, keeping dose size and number of days the same. • Today, you will use MalariaMed to investigate these questions by isolating different variables: either number of days or dose size. How do you think you could use MalariaMed to figure out how dose size might affect a single-drug treatment?
  • 21. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES For today’s testing you and your partner are going to vary the size of the dose, and the number of testable days. For example: One partner could test Drug A for three days at large doses while the other partner tests Drug A for three days at small doses. Interns could then do another test for a different number of days or for a different drug.
  • 22. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES Review the histograms with each test and record observations, just as you did yesterday during the Analyzing Single-Drug Treatments task. Complete at least three tests, and discuss your results and record your ideas on the Conclusions table.
  • 23. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES
  • 24. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES Summarize your conclusions for Total Parasite Population. If you don’t use enough days of the drug, too many parasites can survive and the population will increase. If you use larger doses, more parasites will die (depends on drug) and the population will increase.
  • 25. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES Summarize your conclusions for Drug Resistance. When using large doses, the percentage of resistance is higher after 10 years, and you see parasites with high resistance in fewer years compared to small doses. When using one drug for only 1–3 days, the percentage of resistance is smaller after 10 years, and it takes more years to see parasites with high resistance compared to treatments that are 5–7 days.
  • 26. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES Are the trends the same for all drugs? Discuss why or why not.. Drug B already has individuals with high resistance so using only that drug results in the majority (larger percent) of population with traits for high resistance in fewer years. Drug C is the least effective drug, so it takes longer to see parasites with high resistance, or the final percentage is lower compared to other drugs.
  • 27. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES Summarize your conclusions for Patient Side Effects. In general, fewer days of a drug result in lower side effects, but it depends on the drug. Small doses of a drug result in lower side effects.
  • 28. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES Summarize your conclusions for Total Cost. Fewer days of a drug result in lower costs (depends on drug). Smaller doses cost less so treatment costs are lower.
  • 29. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES Use evidence from the Dossier to help explain why you are seeing these results. If you don’t use large enough doses, even those individuals with some resistance can survive and reproduce to pass on their traits; Those individuals with no resistance are more likely to survive a low dose, and all surviving individuals have a chance of producing offspring that develop mutations for stronger drug resistance; If you don’t use drugs for enough days, you will see something similar—more individuals surviving, reproducing, and possibly producing offspring which have developed traits for higher drug resistance through mutation.
  • 30. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES What might happen to the population if more than one drug is used? Resistance would be minimized because it is likely that the second drug would kill the parasites that were resistant to the first drug.
  • 31. NSEI 4.2 INVESTIGATING MALARIAMED VARIABLES What might happen to the population if more than one drug is used? Resistance would be minimized because it is likely that the second drug would kill the parasites that were resistant to the first drug.
  • 32. NSEI 4.3 AFTER-HOURS WORK Complete the Project Summary form as a prewriting activity for the introduction of the final proposal. You have worked with the different antimalarial drugs today and have learned more about how each contributes to the various project criteria. This form will be submitted to our project leader Ken so he can see what interns understand about the project and some early ideas about malaria treatment designs.